Company
Beam Therapeutics
Beam Therapeutics has 7 drugs tracked on RxWires: 1 approved, 4 in Phase 1/2, 2 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| CLONIDINE HYDROCHLORIDE | Approved | |
| BEAM-201 | Phase 1/2 | Lymphoblastic Lymphoma |
| BEAM-101 | Phase 1/2 | Sickle Cell Disease |
| BEAM-302 | Phase 1/2 | Alpha 1-Antitrypsin Deficiency |
| BEAM-301: Single dose of BEAM-301 administered by IV | Phase 1/2 | Glycogen Storage Disease Type Ia |
| Allogeneic anti-CD7 CAR-T cells (BEAM-201) | Phase 1 | T-Cell Acute Lymphoblastic Leukemia/Lymphoma |
| BEAM-103 | Phase 1 | Healthy Subjects |
Latest
- beam therapeutics filed 8-K
- beam therapeutics filed 8-K
- beam therapeutics filed 8-K
- beam therapeutics filed 8-K
- Licensing / Collaboration Deal: beam therapeutics
Follow Beam Therapeutics on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.